Edition:
United States

Medicines Co (MDCO.OQ)

MDCO.OQ on NASDAQ Stock Exchange Global Select Market

26.59USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$26.59
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
284,497
52-wk High
$41.57
52-wk Low
$24.45

Chart for

About

The Medicines Company is a global biopharmaceutical company. The Company is focused on advancing the treatment of acute and intensive care patients through the delivery of medicines to the hospital marketplace around the world. It markets Angiomax (bivalirudin), Ionsys (fentanyl iontophoretic transdermal system), Minocin... (more)

Overall

Beta: 0.81
Market Cap(Mil.): $2,060.26
Shares Outstanding(Mil.): 73.79
Dividend: --
Yield (%): --

Financials

  MDCO.OQ Industry Sector
P/E (TTM): -- 29.75 32.14
EPS (TTM): -2.40 -- --
ROI: -26.64 13.18 12.83
ROE: -158.61 15.14 14.95

BRIEF-Medicines Co Says CEO Clive A. Meanwell's 2017 Total Compensation Was $7.6 Million

* MEDICINES CO SAYS CEO CLIVE A. MEANWELL'S 2017 TOTAL COMPENSATION WAS $7.6 MILLION VERSUS $6.7 MILLION IN 2016 – SEC FILING Source : https://bit.ly/2KsU3bs Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apr 30 2018

BRIEF-The Medicines Co Reports Q1 GAAP Loss Per Share $1.14 From Continuing Operations

* Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.76 FROM CONTINUING OPERATIONS

Apr 25 2018

Earnings vs. Estimates